Share

Curus invests in FemTech company Ella

16 May - 2022

The first version of the medical mobile application will be launched this spring Ella to help prevent and treat problems during and after pregnancy.
Women’s health is a historically neglected area, but it has received increasing attention in recent years thanks to the growing trend in Femtech.
Ella is now backed by several investors who want to help transform women’s health care.
In August 2021, Ella closed an investment round of just over SEK 6 million, and most recently in March 2022, a round of over 4.5 million was closed.
Among those who have invested in the latest round are Curus and Joo Emmy Sundström, who invested in the tech-driven health and service companies Doktor.se and Dryft. – We want to invest in Femtech, which is an important part of digital health.
Women are much more informed and used to managing their own and others’ health than men, but then there must also be platforms where women get quality and easily accessible support.
We see Ella as the future of maternity care,” says Johan Bloom, CEO of Curus.
Since Ella was founded, the company has been handpicked by both SEB Innovation Forum, SHIFT and awarded by the renowned jury in the 60SecondPitch competition organized by Vaam with tech profile Josef Fallesen at the helm. – Ella is really good.
If Ella is internationally capable then
they have a unique opportunity as the Swedish midwife and maternity care role is on the rise internationally,” says Pär-Jörgen Pärson from Northzone, a jury member of 60SecondPitch, where Ella was crowned the winner. Ella is a medical app that aims to complement both maternity care and aftercare.
In the app, pregnant and newly delivered women will be assigned a personal physiotherapist who follows the women throughout pregnancy and the postpartum period. Together with his physiotherapist, an individualized plan is created with digital care meetings and evidence-based training programs that are continuously updated as conditions change. The programs can both prevent and treat pregnancy-related disorders, which affect at least 90% of all women going through pregnancy, and also help women reach the recommended amount of physical activity. – What makes Ella unique, unlike online doctors, is that we really embrace the benefits of technology.
We build smart algorithms and
ntions that create great value for the user, far beyond healthcare encounters,” says Emelie Hollsten, CEO and founder of Ella. In the future, the app will feature articles, podcasts and courses so that there is something new to learn or discover every day.
An AI is also being developed to predict symptoms and recommend the right care at the right time.
In the future, Ella wants to be a multi-professional care platform specifically adapted for the time during and after pregnancy.
In the upcoming launch, physiotherapy will be the first to go, and then the aim is to offer support from healthcare professions such as psychologists, dieticians, midwives and gynecologists. – We want to become a healthcare provider that both prevents and treats disorders and complications during pregnancy and postpartum.
Our CE marking means that all raw
d and programs in Ella are supported by clinical evidence and that the entire product is quality assured according to European standards for medical devices,” says Frida Johnson, co-founder and head of operations at Ella. For more information: Emelie Hollsten, Founder and CEO, Her Company AB [email protected],+46 703-277 100 Johan Bloom, Founder and CEO, Curus AB [email protected],+46 733-648 490

More news

7 Nov - 2023

Successful health initiative in Region Stockholm exceeds target – more than 50% out of type 2 diabetes risk zone

20 Sep - 2023

Curus invests in Wellon

4 Sep - 2023

Curus Invests in Measurlabs, a Finnish Laboratory Analysis Platform

This website uses cookies to ensure you get the best experience on our website.